196 related articles for article (PubMed ID: 7960982)
21. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
Kim HK; Silver B; Li S; Neuberg D; Mauch P
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteria.
Ha CS; Kavadi V; Dimopoulos MA; Hagemeister FB; Osborne BM; Fuller LM; Smith TL; Hess MA; McLaughlin PW; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):329-34. PubMed ID: 10030257
[TBL] [Abstract][Full Text] [Related]
24. BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.
Rüffer JU; Ballova V; Glossmann J; Sieber M; Franklin J; Nogova L; Diehl V; Josting A;
Leuk Lymphoma; 2005 Nov; 46(11):1561-7. PubMed ID: 16236610
[TBL] [Abstract][Full Text] [Related]
25. Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
Hodgson DC; Tsang RW; Pintilie M; Sun A; Wells W; Crump M; Gospodarowicz MK
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1374-81. PubMed ID: 14630276
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's lymphoma in first relapse following chemotherapy or combined modality therapy: analysis of outcome and prognostic factors after conventional salvage therapy.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Boutsis DE; Anargyrou K; Kokoris SI; Giannakakis A; Karkantaris C; Kyrtsonis MC; Tsaftaridis P; Rombos J; Variamis E; Korkolopoulou P; Kittas C; Pangalis GA
Eur J Haematol; 2002 May; 68(5):289-98. PubMed ID: 12144535
[TBL] [Abstract][Full Text] [Related]
27. Current trend in the treatment of Hodgkin's disease.
Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
[TBL] [Abstract][Full Text] [Related]
28. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
[TBL] [Abstract][Full Text] [Related]
29. Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.
Mauch PM; Canellos GP; Shulman LN; Silver B; Tarbell NJ; Come S; Rabin MS; Coleman CN
J Clin Oncol; 1995 Apr; 13(4):947-52. PubMed ID: 7707123
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy.
Enrici RM; Osti MF; Zurlo A; Anselmo AP; Iacari V; Mandelli F
Eur J Haematol; 1999 Aug; 63(2):126-33. PubMed ID: 10480292
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin's disease stages IA and IIA. A long-term follow-up study on the gains achieved by modern therapy.
Zagars G; Rubin P
Cancer; 1985 Oct; 56(8):1905-12. PubMed ID: 4027927
[TBL] [Abstract][Full Text] [Related]
32. Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
Wirth A; Corry J; Laidlaw C; Matthews J; Liew KH
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):599-607. PubMed ID: 9336139
[TBL] [Abstract][Full Text] [Related]
33. Collaborative clinical trial for stage I and II Hodgkin's disease: significance of mediastinal and nonmediastinal disease in laparotomy- and non-laparotomy-staged patients.
Fuller LM; Hutchison GB
Cancer Treat Rep; 1982 Apr; 66(4):775-87. PubMed ID: 7074648
[TBL] [Abstract][Full Text] [Related]
34. Second malignant tumours in childhood Hodgkin's disease.
Jenkin D; Greenberg M; Fitzgerald A
Med Pediatr Oncol; 1996 Jun; 26(6):373-9. PubMed ID: 8614372
[TBL] [Abstract][Full Text] [Related]
35. [Therapeutic implications of the peculiar clinical characteristics of Hodgkin's disease in clinical stages I-II with isolated neck presentation].
Magrini SM; Cellai E; Papi MG; Pertici M; Lastrucci L; Ponticelli P; Sulprizio S; Biti G
Radiol Med; 1995; 90(1-2):108-12. PubMed ID: 7569074
[TBL] [Abstract][Full Text] [Related]
36. Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group.
Shankar AG; Ashley S; Radford M; Barrett A; Wright D; Pinkerton CR
J Clin Oncol; 1997 Jul; 15(7):2622-30. PubMed ID: 9215833
[TBL] [Abstract][Full Text] [Related]
37. Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
Berkowicz M; Rath P; Aghai E; Many A; Ben-Bassat I; Hulu N; Ramot B; Brenner H
Isr J Med Sci; 1978 Dec; 14(12):1275-82. PubMed ID: 748241
[TBL] [Abstract][Full Text] [Related]
38. Results of treating Hodgkin's disease without a policy of laparotomy staging.
Bergsagel DE; Alison RE; Bean HA; Brown TC; Bush RS; Clark RM; Chua T; Dalley D; DeBoer G; Gospodarowicz M; Hasselback R; Perrault D; Rideout DF
Cancer Treat Rep; 1982 Apr; 66(4):717-31. PubMed ID: 7074642
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
Roach M; Brophy N; Cox R; Varghese A; Hoppe RT
J Clin Oncol; 1990 Apr; 8(4):623-9. PubMed ID: 2313331
[TBL] [Abstract][Full Text] [Related]
40. Risk factor adapted treatment of Hodgkin's lymphoma: strategies and perspectives.
Loeffler M; Pfreundschuh M; Rühl U; Hiller E; Gerhartz H; Roloff R; Adler M; Schoppe W; Hagen-Aukamp U; Schmitt G
Recent Results Cancer Res; 1989; 117():142-62. PubMed ID: 2690225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
